Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00651495 · ClinicalTrials.gov registry record · NA

Activating Seniors to Improve Chronic Disease Care

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
116
Enrollment target

NCT00651495: Completed NA study, sponsored by University of California, Los Angeles.

NCT00651495 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 116 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00651495, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
116 participants
Enrollment target

Study Summary

Chronic diseases are the primary cause of morbidity and mortality for older Americans. Active patient participation in treatment decision-making has the potential to significantly improve outcomes in chronic disease care, but interventions to increase participation remain underused. Some studies have found that older individuals are less interested in participating in clinical decision-making, but other studies find that exposing patients to decision aids (PtDAs) increases their desire to take an active role in making decisions with their physicians. The present study targets hard-to-reach seniors by showing decision aids focused on chronic disease management in senior centers. Decision aids will be made available in two senior centers through a lending library and by conducting group screenings of the decision aids followed by moderated discussion of the content with participants. A randomized encouragement design will be used to test the effectiveness of a modest financial incentive on increasing seniors' participation in group screenings. The investigators will evaluate the effects of the intervention on seniors' decision-making role preferences, attitudes, perceived social norms and self efficacy for asking questions of their physician, health-related quality of life, physical activity, and changes in prescribed treatment regimens and self-care.

Interventions

  • BEHAVIORAL Patient decision aids for chronic conditions

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2008-04
Est. Completion 2008-11
Phase NA

What the finished NCT00651495 record still lists

NCT00651495 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which Patient decision aids for chronic conditions is the first listed.

NCT00651495 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00651495 about?

NCT00651495 is a clinical study titled "Activating Seniors to Improve Chronic Disease Care". Chronic diseases are the primary cause of morbidity and mortality for older Americans. Active patient participation in treatment decision-making has the potential to significantly improve outcomes in chronic disease care, but interventions to increase participation remain underused. Some studies hav...

What is the current status of trial NCT00651495?

This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2008-04. Estimated completion is 2008-11.

What interventions are being tested in trial NCT00651495?

The interventions under investigation include: Patient decision aids for chronic conditions (BEHAVIORAL).

Who is sponsoring clinical trial NCT00651495?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00651495's enrollment target sits among peer trials

116 808th of 2000 higher than 1,191 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03014687 · 116 participants · Phase 4

    Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions

  • NCT03214562 · 116 participants · Phase 1

    Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

  • NCT03847467 · 116 participants · Phase 1

    Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy

  • NCT04222413 · 116 participants · Phase 1

    Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00651495, the US trial registry maintained by the National Library of Medicine. NCT00651495 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.